Media
Corporate Governance
Investors
Career
Swedish
English
ENZY
4.55
SEK
-1.30%
Enzyme science
Products
Research & Development
Company
Contact
Enzymatica Main Page
Investors
Prospectus
Investors
Prospectus
12 May, 2021
Rights issue 2021
1 November, 2018
Rights issue 2018
1 April, 2016
Rights Issue 2016
Enzymatica on First North Growth Market
Investment case
Risks
The share
Financial reports
Prospectus
Presentations
Financial calendar
Investor Relations Contact
Press releases
Subscribe